Reversing enhancer RNA–mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer models
- Journal:
- Journal of Clinical Investigation
- Published:
- DOI:
- 10.1172/jci190928
- Affiliations:
- 10
- Authors:
- 17
| Institutions | Authors | Share |
|---|---|---|
| Mayo Clinic, United States of America (USA) | 0.49 | |
| First Affiliated Hospital, ZZU, China | 0.25 | |
| Zhengzhou University (ZZU), China | 0.08 | |
| Children's Hospital, Zhejiang University School of Medicine, China | 0.06 | |
| The First Hospital of Jiaxing, China | 0.06 | |
| Changhai Hospital, SMMU, China | 0.06 |